Chromosome 16 in primary prostate cancer: A microsatellite analysis

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 580-584

  Osman, Iman ^a   Scher, Howard ^a   Dalbagni, Guido ^a   Reuter, Victor ^a   Zhang, Zuo Feng ^a   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 16; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 16; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICROSATELLITE REPEATS; PROSTATIC NEOPLASMS; SEQUENCE DELETION;

EID: 0030990042     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<580::AID-IJC12>3.0.CO;2-G     Document Type: Article

References (29)

1. AUSTRUY, E., JEANPIERRE, C., ANTIGNAC, C., WHITMOKE, S.A., VAN CONG, N., BERNHEIM, A., CALLEN, D.F. and JUNIEN, C., Physical and genetic mapping of the dipeptidase gene DPEP to 16q24.3. Genomics, 15, 684-687 (1993).
2. BERGERHEIM, U.S.R., KUNIMI, K., COLLINS, V.P. and EKMAN, P., Deletion mapping of chromosomes 8, 10 and 16 in human prostate carcinoma. Genes Chromosomes Cancer, 3, 215-220 (1991).
3. CALLEN, D.F. and 16 OTHERS, High resolution cytogenetic-based physical map of human chromosome 16. Genomics, 13, 1178-1185 (1992).
4. CARTER, B.S., EWING, C.M., WARD, W.S., TREIGER, B.F., AALDERS, T.W., SCHALKEN, J.A., EPSTEIN, J.I. and ISAACS, W.B., Allelic losses of chromosomes 16q and 10q in human prostate cancer. Proc. nat. Acad. Sci. (Wash.), 87, 8751-8755 (1990).
5. CHER, M.L., ITO, T., WEIDNER, N., CARROLL, P.R. and JENSEN, R.H., Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by (FISH). J. Urol., 153, 249-254 (1995).
6. CUTICCHI, A.J., CHIPPERFIELD, M.A. and MAIDAK, B.L., Polymorphic PCR detection markers of man. In: S.J. O'Brian (ed.), Locus maps of complex genomes, 6th ed., pp. 128-175. Cold Spring Harbor Laboratory Press, New York (1993).
7. DALBAGNI, G., PRESTI, J., REUTER, V.E., FAIR, W.R. and CORDON-CARDO, C., Genetic alterations in bladder cancer. Lancet, 342, 469-171 (1993).
8. EGAWA, S., UCHIDA, T., SYAMA, K., WANG, C., OHORI, M., IRIE, S., IWAMURA, M. and KOSHIBA, K., Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res., 55, 2418-2421 (1995).
9. FEARON, E.R., HAMILTON, S.R. and VOGELSTEIN, B., Clonal analysis of human colorectal tumors. Science, 238, 193-197 (1987).
10. GAO, X., WU, N., GRIGNON, D., ZACHAREK, A., LIU, H., SALKOWSKI, A., LI, G., SAKR, W., SARKAR, F., PORTER, A.T., CHEN, Y.Q. and HONN, K.V., High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene, 9, 2999-3003 (1994).
11. GYAPAY, G., MORISSETTE, J., VIGNAL, A., DIB, C., FIZAMES, C., MILLASSEAU, P., MARC, S., BERNARDI, G., LATHROP, M. and WEISSENBACH, J., The 1993-1994 Genethon human genetic linkage map. Nature (Genet.), 7, 314-317 (1994).
12. ISAACS, W.B., BOVA, G.S., MORTON, R.A., BUSSEMAKERS, M.J.G., BROOKS, J.D. and EWING, C.M., Molecular biology of prostate cancer. Semin. Oncol., 214, 517-521 (1994).
13. JANSEN, A.-M.C., MOERLAND, E.W., KUIPERS-DIJKSHOORN, N.J., CALLEN, D.F., SUTHERLAND, G.R., DEVILEE, P., HANSEN, B. and CORNELISSE, C.J., At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer, 9, 101-107 (1994).
14. KAUPMANN, K., BECKER-FOLLMANN, J., SCHERER, G., JOCKUSCH, H. and STARZINSKI-POWITZ, A., The gene for cell adhesion molecular M-cadherin maps to mouse chromosome 8 and human chromosome 16q24.1-qter and is near the E-cadherin locus in both species. Genomics, 14, 488-490 (1992).
15. KOYAMA, K., EMI, M. and NAKAMURA, Y., The cell adhesion regulator (CAR) gene. Taq1 and insertion/deletion polymorphism and regional assignment to the peritelomeric region of 16q by linkage analysis. Genomics, 16, 264-265 (1993).
16. KUNIMI, K., BERGERHEIM, U.S.R., LARSSON, I.L., EKMAN, P. and COLLINS, V.P., Allelotyping of human prostatic carcinoma. Genomics, 11, 530-536 (1991).
17. LACOMBE, L., ORLGW, I., REUTER, V.E., FAIR, W.R., DALBAGNI, G., ZHANG, Z.-F. and CORDON-CARDO, C., Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. Int. J. Cancer, 69, 110-113 (1996).
18. LANDIS, R.J., HERMAN, E.R. and KOCH, G.G., Average partial association in three-way contigency tables: a review and discussion of alternative tests. Int. Statist. Rev., 46, 537-254 (1986).
19. LUNDGREN, R., MANDHAL, N., HEIM, S., LIMON, J., HENRIKSON, H. and MITELMAN, F., Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer, 4, 16-24 (1992).
20. MACOSKA, J.A., TRYBUS, T.M., SAKR, W.A., WOLF, M.C., BENSON, P.D., POWELL, I.J. and PONTES, J.E., Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer 54, 3824-3830 (1994).
21. MASSENKEIL, G., OBERHUBER, H,. HAILERMARIAN, S., SULSER, T., DIENER, P.A., BANNWANT, F., SCHAFER, R. and SCHWARTE-WALDHOPP, I., p53 mutations and loss of heterozygosity on chromosome 8p. 16q. 17p and 18q are confined to advanced prostate cancer. Cancer Res., 14, 2789-2794 (1994).
22. MEHTA, C.R. and PATEL, N.R., A network algorithm for performing Fisher's exact test contingency tables. J. Amer. Statist. Ass., 78, 427-434 (1983).
23. PHILIP, S.M.A., MORTON, D.G., LEE, S.J., WALLACE, D.M.A. and NEOPTOLEMOS, J.P., Loss of heterozygosity of the retinoblastoma gene and adenomatous polyposis susceptibility gene loci in chromosomes 10 p. 10q an 16q in human prostate cancer. Brit. J. Urol., 73, 390-395 (1994).
24. RADFORD, D.M., FAIR, K.L., PHILLIP, N.J., RITTER, J., STEINBRUCK, T., HOLT, M.S. and DONISKELLER, H., Allelotyping of ductal carcinoma in situ of the breast. Deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res., 55, 3399-3405 (1995).
25. SAKR, W.A., MACOSKA, J.A., BENSON, P., GRIGNON, D.J., WOLAMN, S.R., PONTES, E. and CRISSMAN, J.D., Allelic loss in locally metastatic multi-sampled prostate cancer. Cancer Res., 54, 3273-3277 (1994).
26. THOMPSON, A., SHEN, Y., HOLMAN, K., SUTHERLAND, G., CALLEN, D. and RICHARDS, R., Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. Genomics, 13, 402-408 (1992).
27. UMBAS, R., ISAACS, W.B., BRINGUIER, P.P., SCHAAFSMA, H.E., KARTHAUS, H.F.M., OOSTERHOF, G.O.N., DEBRUYNE, F.M.J. and SCHALKEN, J.A., Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54, 3929-3933 (1994).
28. VISAKORPI, T., KALLIONIEMI, A.H., SYVANEN, A.C., HYYTINEN, E.R., KARHU, R., TAMMELA, T., ISOLA, J.J. and KALLIONIEMI, O.P., Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55, 342-347 (1995).
29. WEISSENBACH, J., GYAPAY, G., DIB, C., VIGNAL, A., MORISSETTE, J., MILLASSEAU, P., VAYSSEIX, G. and LATHROP, M., A second generation linkage map of the human genome. Nature (Lond.), 359, 794-801 (1992).